C8B in Complement and Coagulation Cascades Signaling Pathway is a predictor for Survival in HBV-Related Hepatocellular Carcinoma Patients

References

• The International Agency for Research on Cancer. Latest global cancer data: cancer burden rises to 19.3 million new cases and 10.0 million cancer deaths in 2020; 2020. https://www.iarc.who.int/wp-content/uploads/2020/2012/pr2292_E.pdf.
   Google Scholar
• Pandyarajan V, Govalan R, Yang JD. Risk factors and biomarkers for chronic hepatitis B associated hepatocellular carcinoma. Int J Mol Sci. 2021;22(2):479. doi:10.3390/ijms22020479
   PubMed Web of Science ®Google Scholar
• Sharma R. Descriptive epidemiology of incidence and mortality of primary liver cancer in 185 countries: evidence from GLOBOCAN 2018. Jpn J Clin Oncol. 2020;50(12):1370–1379. doi:10.1093/jjco/hyaa13032719873
   PubMed Web of Science ®Google Scholar
• Yan SY, Fan JG, Qio L. Hepatitis B Virus (HBV) infection and hepatocellular carcinoma- new insights for an old topic. Curr Cancer Drug Targets. 2017;17(6):505–511. doi:10.2174/156800961666616092612453027677954
   PubMed Web of Science ®Google Scholar
• Girardi DM, Pacifico JPM, Guedes de Amorim FPL, et al. Immunotherapy and targeted therapy for hepatocellular carcinoma: a literature review and treatment perspectives. Pharmaceuticals. 2020;14(1):28. doi:10.3390/ph1401002833396181
   PubMed Web of Science ®Google Scholar
• Kudo M. Recent Advances in Systemic Therapy for Hepatocellular Carcinoma in an Aging Society: 2020 Update. Liver Cancer. 2020;9(6):640–662. doi:10.1159/00051100133442538
   PubMed Web of Science ®Google Scholar
• Omata M, Cheng AL, Kokudo N, et al. Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update. Hepatol Int. 2017;11(4):317–370.28620797
   PubMed Web of Science ®Google Scholar
• Mejia JC, Pasko J. Primary Liver Cancers: intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma. Surg Clin North Am. 2020;100(3):535–549. doi:10.1016/j.suc.2020.02.01332402299
   PubMed Web of Science ®Google Scholar
• Petrick JL, Kelly SP, Altekruse SF, McGlynn KA, Rosenberg PS. Future of Hepatocellular Carcinoma Incidence in the United States Forecast Through 2030. J Clin Oncol. 2016;34(15):1787–1794. doi:10.1200/JCO.2015.64.741227044939
   PubMed Web of Science ®Google Scholar
• Teufel A. Bioinformatics and database resources in hepatology. J Hepatol. 2015;62(3):712–719. doi:10.1016/j.jhep.2014.10.03625450718
   PubMed Web of Science ®Google Scholar
• Wang L, Yang Z, Cao Y. Regulatory T cell and activated natural killer cell infiltration in hepatocellular carcinoma: immune cell profiling using the CIBERSORT. Ann Transl Med. 2020;8(22):1483. doi:10.21037/atm-20-583033313228
   PubMed Web of Science ®Google Scholar
• Zhang Y, Yang L, Shi J, Lu Y, Chen X, Yang Z. The Oncogenic Role of CENPA in hepatocellular carcinoma development: evidence from bioinformatic analysis. Biomed Res Int. 2020;2020:3040839.32337237
   PubMed Web of Science ®Google Scholar
• Muller-Calleja N, Ritter S, Hollerbach A, Falter T, Lackner KJ, Ruf W. Complement C5 but not C3 is expendable for tissue factor activation by cofactor-independent antiphospholipid antibodies. Blood Adv. 2018;2(9):979–986. doi:10.1182/bloodadvances.201801709529716893
   PubMed Web of Science ®Google Scholar
• Chen L, Yue J, Han X, Li J, Hu Y. Ouabain rescues rat nephrogenesis during intrauterine growth restriction by regulating the complement and coagulation cascades and calcium signaling pathway. J Dev Orig Health Dis. 2016;7(1):91–101. doi:10.1017/S204017441500724226442628
   PubMed Web of Science ®Google Scholar
• Liu W. Complement proteins detected through iTRAQ-based proteomics analysis of serum from black carp Mylopharyngodon piceus in response to experimentally induced Aeromonas hydrophila infection. Dis Aquat Organ. 2020;140:187–201. doi:10.3354/dao0349732815527
   PubMed Web of Science ®Google Scholar
• Zhang J, Chen M, Zhao Y, et al. Complement and coagulation cascades pathway correlates with chemosensitivity and overall survival in patients with soft tissue sarcoma. Eur J Pharmacol. 2020;879:173121. doi:10.1016/j.ejphar.2020.17312132339514
   PubMed Web of Science ®Google Scholar
• Liu Y, Xiong S, Liu S, et al. Analysis of gene expression in bladder cancer: possible involvement of mitosis and complement and coagulation cascades signaling pathway. J Comput Biol. 2020;27(6):987–998. doi:10.1089/cmb.2019.023731545079
   PubMed Web of Science ®Google Scholar
• Castiblanco-Valencia MM, Fraga TR, Pagotto AH, et al. Plasmin cleaves fibrinogen and the human complement proteins C3b and C5 in the presence of Leptospira interrogans proteins: a new role of LigA and LigB in invasion and complement immune evasion. Immunobiology. 2016;221(5):679–689. doi:10.1016/j.imbio.2016.01.00126822552
   PubMed Web of Science ®Google Scholar
• Ekdahl KN, Teramura Y, Asif S, Jonsson N, Magnusson PU, Nilsson B. Thromboinflammation in Therapeutic Medicine. Adv Exp Med Biol. 2015;865:3–17.26306440
   PubMed Web of Science ®Google Scholar
• Nilsson B, Teramura Y, Ekdahl KN. The role and regulation of complement activation as part of the thromboinflammation elicited in cell therapies. Mol Immunol. 2014;61(2):185–190. doi:10.1016/j.molimm.2014.06.00924998801
   PubMed Web of Science ®Google Scholar
• Palacios-Acedo AL, Mege D, Crescence L, Dignat-George F, Dubois C, Panicot-Dubois L. Platelets, Thrombo-Inflammation, and Cancer: collaborating With the Enemy. Front Immunol. 2019;10:1805. doi:10.3389/fimmu.2019.0180531417569
   PubMed Web of Science ®Google Scholar
• Schattner M, Jenne CN, Negrotto S, Ho-Tin-Noe B. Editorial: platelets and immune responses during thromboinflammation. Front Immunol. 2020;11:1079. doi:10.3389/fimmu.2020.0107932547562
   PubMed Web of Science ®Google Scholar
• Suzuki-Inoue K. Platelets and cancer-associated thrombosis: focusing on the platelet activation receptor CLEC-2 and podoplanin. Blood. 2019;134(22):1912–1918. doi:10.1182/blood.201900138831778548
   PubMed Web of Science ®Google Scholar
• Roessler S, Jia HL, Budhu A, et al. A unique metastasis gene signature enables prediction of tumor relapse in early-stage hepatocellular carcinoma patients. Cancer Res. 2010;70(24):10202–10212. doi:10.1158/0008-5472.CAN-10-260721159642
   PubMed Web of Science ®Google Scholar
• Roessler S, Long EL, Budhu A, et al. Integrative genomic identification of genes on 8p associated with hepatocellular carcinoma progression and patient survival. Gastroenterology. 2012;142(4):957–966 e912. doi:10.1053/j.gastro.2011.12.03922202459
   PubMed Web of Science ®Google Scholar
• Gautier L, Cope L, Bolstad BM, Irizarry RA. affy–analysis of Affymetrix GeneChip data at the probe level. Bioinformatics. 2004;20(3):307–315. doi:10.1093/bioinformatics/btg40514960456
   PubMed Web of Science ®Google Scholar
• Dong X, Lin L, Zhang R, et al. TOBMI: trans-omics block missing data imputation using a k-nearest neighbor weighted approach. Bioinformatics. 2019;35(8):1278–1283. doi:10.1093/bioinformatics/bty79630202885
   PubMed Web of Science ®Google Scholar
• Ritchie ME, Phipson B, Wu D, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43(7):e47. doi:10.1093/nar/gkv00725605792
   PubMed Web of Science ®Google Scholar
• Yu G, Wang LG, Han Y, He QY. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012;16(5):284–287. doi:10.1089/omi.2011.011822455463
   PubMed Web of Science ®Google Scholar
• Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017;45(W1):W98–W102. doi:10.1093/nar/gkx24728407145
   PubMed Web of Science ®Google Scholar
• Menyhart O, Nagy A, Gyorffy B. Determining consistent prognostic biomarkers of overall survival and vascular invasion in hepatocellular carcinoma. R Soc Open Sci. 2018;5(12):181006. doi:10.1098/rsos.18100630662724
   PubMed Web of Science ®Google Scholar
• Nagy A, Lanczky A, Menyhart O, Gyorffy B. Validation of miRNA prognostic power in hepatocellular carcinoma using expression data of independent datasets. Sci Rep. 2018;8(1):9227. doi:10.1038/s41598-018-27521-y29907753
   PubMed Web of Science ®Google Scholar
• Revel M, Daugan MV, Sautes-Fridman C, Fridman WH, Roumenina LT. Complement system: promoter or suppressor of cancer progression? Antibodies. 2020;9(4). doi:10.3390/antib9040057
   Web of Science ®Google Scholar
• Thurman JM, Laskowski J, Nemenoff RA. Complement and Cancer-A Dysfunctional Relationship? Antibodies. 2020;9(4). doi:10.3390/antib9040061
   Web of Science ®Google Scholar
• Li L, Yang W, Shen Y, Xu X, Li J. Fish complement C8 evolution, functional network analyses, and the theoretical interaction between C8 alpha chain and CD59. Mol Immunol. 2020;128:235–248. doi:10.1016/j.molimm.2020.10.01333160183
   PubMed Web of Science ®Google Scholar
• Plumb ME, Scibek JJ, Barber TD, Dunlap RJ, Platteborze PL, Sodetz JM. Chimeric and truncated forms of human complement protein C8 alpha reveal binding sites for C8 beta and C8 gamma within the membrane attack complex/perforin region. Biochemistry. 1999;38(26):8478–8484. doi:10.1021/bi990485810387094
   PubMed Web of Science ®Google Scholar
• Grumach AS, Kirschfink M. Are complement deficiencies really rare? Overview on prevalence, clinical importance and modern diagnostic approach. Mol Immunol. 2014;61(2):110–117. doi:10.1016/j.molimm.2014.06.03025037634
   PubMed Web of Science ®Google Scholar
• Turley AJ, Gathmann B, Bangs C, et al. Spectrum and management of complement immunodeficiencies (excluding hereditary angioedema) across Europe. J Clin Immunol. 2015;35(2):199–205. doi:10.1007/s10875-015-0137-525663093
   PubMed Web of Science ®Google Scholar
• Kaufmann T, Hansch G, Rittner C, Spath P, Tedesco F, Schneider PM. Genetic basis of human complement C8 beta deficiency. J Immunol. 1993;150(11):4943–4947.8098723
   PubMed Web of Science ®Google Scholar
• Rao L, Li YB, Chen GD, Zhou B, Schneider PM, Zhang L. [Further study on heterogeneic basis of complement C8 beta deficiency]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2004;21(1):10–13. Chinese.14767900
   PubMedGoogle Scholar
• Bradley DT, Bourke TW, Fairley DJ, et al. Susceptibility to invasive meningococcal disease: polymorphism of complement system genes and Neisseria meningitidis factor H binding protein. PLoS One. 2015;10(3):e0120757. doi:10.1371/journal.pone.012075725798599
   PubMed Web of Science ®Google Scholar
• Dellepiane RM, Dell’Era L, Pavesi P, et al. Invasive meningococcal disease in three siblings with hereditary deficiency of the 8(th) component of complement: evidence for the importance of an early diagnosis. Orphanet J Rare Dis. 2016;11(1):64. doi:10.1186/s13023-016-0448-527183977
   PubMed Web of Science ®Google Scholar
• Karlsson E, Shaat N, Groop L. Can complement factors 5 and 8 and transthyretin be used as biomarkers for MODY 1 (HNF4A-MODY) and MODY 3 (HNF1A-MODY)? Diabet Med. 2008;25(7):788–791. doi:10.1111/j.1464-5491.2008.02467.x18513302
   PubMed Web of Science ®Google Scholar
• Ye Z, Zeng Z, Shen Y, Chen Z. Identification of hub genes in peripheral blood mononuclear cells for the diagnosis of hepatocellular carcinoma using a weighted gene co-expression network analysis. Exp Ther Med. 2020;20(2):890–900. doi:10.3892/etm.2020.873632742331
   PubMed Web of Science ®Google Scholar
• Akhir FNM, Noor MHM, Leong KWK, et al. An Immunoregulatory role for complement receptors in murine models of breast cancer. Antibodies. 2021;10(1). doi:10.3390/antib10010002
   Web of Science ®Google Scholar
• Kavvadas E. Autoantibodies specific for C1q, C3b, beta2-glycoprotein 1 and annexins may amplify complement activity and reduce apoptosis-mediated immune suppression. Med Hypotheses. 2020;144:110286. doi:10.1016/j.mehy.2020.11028633254588
   PubMed Web of Science ®Google Scholar
• Repetto O, Maiero S, Magris R, et al. Quantitative Proteomic Approach Targeted to Fibrinogen beta Chain in Tissue Gastric Carcinoma. Int J Mol Sci. 2018;19(3). doi:10.3390/ijms19030759
   Web of Science ®Google Scholar
• Feng Z, Wen H, Bi R, Duan Y, Yang W, Wu X. Thrombocytosis and hyperfibrinogenemia are predictive factors of clinical outcomes in high-grade serous ovarian cancer patients. BMC Cancer. 2016;16(1):43. doi:10.1186/s12885-016-2070-226817451
   PubMed Web of Science ®Google Scholar
• Lee KW, Bang SM, Kim S, et al. The incidence, risk factors and prognostic implications of venous thromboembolism in patients with gastric cancer. J Thromb Haemost. 2010;8(3):540–547. doi:10.1111/j.1538-7836.2009.03731.x20040044
   PubMed Web of Science ®Google Scholar
• Li H, Zhao T, Ji X, et al. Hyperfibrinogenemia predicts poor prognosis in patients with advanced biliary tract cancer. Tumour Biol. 2016;37(3):3535–3542. doi:10.1007/s13277-015-4184-626453118
   PubMedGoogle Scholar
• Wang H, Gao J, Bai M, et al. The pretreatment platelet and plasma fibrinogen level correlate with tumor progression and metastasis in patients with pancreatic cancer. Platelets. 2014;25(5):382–387. doi:10.3109/09537104.2013.82778224001199
   PubMed Web of Science ®Google Scholar
• Repetto O, De Re V. Coagulation and fibrinolysis in gastric cancer. Ann N Y Acad Sci. 2017;1404(1):27–48. doi:10.1111/nyas.1345428833193
   PubMed Web of Science ®Google Scholar
• Kong W, Xu H, Cheng J, et al. The Prognostic role of a combined fibrinogen and neutrophil-to-lymphocyte ratio score in patients with resectable hepatocellular carcinoma: a Retrospective Study. Med Sci Monit. 2020;26:e918824. doi:10.12659/MSM.91882431929496
   PubMed Web of Science ®Google Scholar
• Zhang X, Long Q. Elevated serum plasma fibrinogen is associated with advanced tumor stage and poor survival in hepatocellular carcinoma patients. Medicine. 2017;96(17):e6694. doi:10.1097/MD.000000000000669428445272
   PubMed Web of Science ®Google Scholar
• Yang W, Shi J, Zhou Y, et al. Co-expression network analysis identified key proteins in association with hepatic metastatic colorectal cancer. Proteomics Clin Appl. 2019;13(6):e1900017. doi:10.1002/prca.20190001731397080
   PubMed Web of Science ®Google Scholar
• He J, Zeng ZC, Xiang ZL, Yang P. Mass spectrometry-based serum peptide profiling in hepatocellular carcinoma with bone metastasis. World J Gastroenterol. 2014;20(11):3025–3032. doi:10.3748/wjg.v20.i11.302524659894
   PubMed Web of Science ®Google Scholar